scholarly journals In Vivo Tumor Delivery of a Recombinant Single Chain Fv::Tumor Necrosis Factor-α Fusion Protein

2002 ◽  
Vol 13 (2) ◽  
pp. 385-385 ◽  
Author(s):  
Stephen P. Cooke ◽  
R. Barbara Pedley ◽  
R. Boden ◽  
Richard H. J. Begent ◽  
Kerry A. Chester
2002 ◽  
Vol 13 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Stephen P. Cooke ◽  
R. Barbara Pedley ◽  
R. Boden ◽  
Richard H. J. Begent ◽  
Kerry A. Chester

Endocrinology ◽  
1998 ◽  
Vol 139 (5) ◽  
pp. 2278-2283 ◽  
Author(s):  
Brian N. Finck ◽  
Keith W. Kelley ◽  
Robert Dantzer ◽  
Rodney W. Johnson

2020 ◽  
Author(s):  
Asgar Barkhordaria ◽  
Karim Mahnam ◽  
Hamid Mir Mohammad Sadeghi

Abstract Background: Rheumatoid arthritis disease is a chronic autoimmune inflammatory disease that mainly causes synovial joint inflammation and cartilage destruction. Tumor necrosis factor-α (TNF-α) is a pivotal cytokine that plays an important role in rheumatoid arthritis. The treatments focusing on a single cytokine' inhibition, are able to clinically produce meaningful responses in only about half of the treated patients due to multiple cytokines involved in this disease. In the present study, a bi-specific tandem single-chain variable fragment was designed in order to suppress both human tumor necrosis factor-α and interleukin-23 (IL23) as a potential therapeutic drug candidate for this disease. To do so, at first, eight bi-specific tandem single-chain variable fragment models were built against tumor necrosis factor-α and interleukin-23 cytokines with different domain orders and then 50 ns molecular dynamics simulation was performed for each one and thereafter structural properties were exploited. Results: MD simulation results indicate that the domains' order strongly affects tandem single-chain variable fragment properties and in overall, the fragment VLIL23+Linker+VHIL23+linker+VLTNF+Linker+VHTNF +His6 (VL is variable light and VH is variable heavy fragments and His6 is six histidine) not only separated antibody domains but also had better stability and solvation energy. Conclusions: Hence, this structure can be considered as a potential drug for rheumatoid arthritis. It is hoped that this research could shed a light for the treatment of Rheumatoid arthritis disease.


1999 ◽  
Vol 277 (3) ◽  
pp. G671-G677 ◽  
Author(s):  
Nobuyuki Enomoto ◽  
Shunhei Yamashina ◽  
Peter Schemmer ◽  
Chantal A. Rivera ◽  
Blair U. Bradford ◽  
...  

The relationship between gender and alcohol-induced liver disease is complex; however, endotoxin is most likely involved. Recently, it was reported that estriol activated Kupffer cells by upregulation of the endotoxin receptor CD14. Therefore, the purpose of this work was to study how estriol sensitizes Kupffer cells. Rats were given estriol (20 mg/kg ip), and Kupffer cells were isolated 24 h later. After addition of lipopolysaccharide (LPS), intracellular Ca2+ concentration was measured using a microspectrofluorometer with the fluorescent indicator fura 2, and tumor necrosis factor-α was measured by ELISA. CD14 was evaluated by Western analysis. One-half of the rats given estriol intraperitoneally 24 h before an injection of a sublethal dose of LPS (5 mg/kg) died within 24 h, whereas none of the control rats died. Mortality was prevented totally by sterilization of the gut with antibiotics. A similar pattern was obtained with liver histology and serum transaminases. Translocation of horseradish peroxidase was increased about threefold in gut segments by treatment with estriol. This increase was not altered by treatment with nonabsorbable antibiotics. On the other hand, endotoxin levels were increased to 60–70 pg/ml in plasma of rats treated with estriol. As expected, this increase was prevented (<20 pg/ml) by antibiotics. In isolated Kupffer cells, LPS-induced increases in intracellular Ca2+ concentration, tumor necrosis factor-α production, and CD14 were increased, as previously reported. All these phenomena were blocked by antibiotics. Therefore, it is concluded that estriol treatment in vivo sensitizes Kupffer cells to LPS via mechanisms dependent on increases in CD14. This is most likely due to elevated portal blood endotoxin caused by increased gut permeability.


1988 ◽  
Vol 18 (12) ◽  
pp. 2085-2088 ◽  
Author(s):  
Michael Huber ◽  
Bruce Beutler ◽  
Dietrich Keppler

Sign in / Sign up

Export Citation Format

Share Document